Invention Application
US20140286948A1 METHODS FOR TREATING SCLERODERMA BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE
审中-公开
通过管理可溶性CTLA4分子来治疗SCLERODERMA的方法
- Patent Title: METHODS FOR TREATING SCLERODERMA BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE
- Patent Title (中): 通过管理可溶性CTLA4分子来治疗SCLERODERMA的方法
-
Application No.: US14193687Application Date: 2014-02-28
-
Publication No.: US20140286948A1Publication Date: 2014-09-25
- Inventor: Robert COHEN , Suzette Belder-Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant: Bristol-Myers Squibb Company
- Main IPC: C07K14/705
- IPC: C07K14/705
Abstract:
The present invention relates to compositions and methods for treating autoimmune diseases, such as scleroderma, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Public/Granted literature
- US09296808B2 Methods for treating scleroderma by administering a soluble CTLA4 molecule Public/Granted day:2016-03-29
Information query
